RPG Group
Search results
Zensar is a global organization which conceptualizes, builds, and manages digital products through experience design, data engineering, and advanced analytics for over 200 leading companies.
Zensar is a leading technology solutions company with a strong engineering pedigree. Headquartered in Pune, India, we are part of the USD 4.4 billion RPG Group, serving over 145 global clients.
Zensar Technologies Limited is an Indian publicly traded software and services company. The company's stock trades on the Bombay Stock Exchange and on the National Stock Exchange of India . [4] A subsidiary of RPG Group , the company's chairman is Harsh Goenka .
Zensar Technologies | 866,151 followers on LinkedIn. We are ‘experience-led everything’ — harnessing the power of technology, creativity, and insight to deliver impact. | Zensar stands out as a...
zensar.com. 39. Zensar Technologies | 864,674 followers on LinkedIn. We are ‘experience-led everything’ — harnessing the power of technology, creativity, and insight to deliver impact ...
Story by Nehal Chaliawala. • 22h. N ew Dehli: Zensar Technologies Ltd is set to acquire BridgeView Life Sciences, an American information technology (IT) and operations services firm, in an all ...
At Zensar, we learn, disrupt, and grow together. Explore job opportunities and apply today to supercharge your career in a high-performance workplace.
4 days ago · Zensar Technologies Limited Stock Price Today, Live NSE Share Price: Get the latest Zensar Technologies Limited news, company updates, quotes, tips, historical charts, 52 week high low, market performance financial reports and many more at NSE India.
2 days ago · Zensar Tech Share Price Today (18 Jul, 2024): Zensar Tech Stock Price (₹ 790.30) Live NSE/BSE updates on The Economic Times. Check out why Zensar Tech share price is up today. Get all details on Zensar Technologies shares news and analysis, Forecasts, Dividend, balance sheet, profit & loss, Quarterly results, annual report information, and more
3 days ago · Zensar Technologies, has agreed to acquire a 100% membership interest in three-year old US-based BridgeView Life Sciences, through its wholly owned subsidiary Zensar Technologies Inc, USA, for a total consideration of $25 million. Under the terms, Zensar said will make an aggregate upfront payment of $14.0 million subject to customary adjustments for working capital, debt and cash on closing and additional payment upto $11.0 million by 31 December, 2027 contingent on achievement of ...
